BLCO Intrinsic Stock Value – BAUSCH & LOMB Announces Second Quarter Earnings Results for FY2023

August 14, 2023

🌥️Earnings Overview

BAUSCH & LOMB ($NYSE:BLCO) released their second quarter of FY2023 earnings results on August 2 2023, with total revenue increasing 10.0% year-over-year to USD 1035.0 million. However, the reported net income of USD -32.0 million was a decrease from the previous year’s net income of USD 5.0 million.

Market Price

The company reported a decrease in their stock price, with the opening price being $19.2 and the closing price being $18.9, down 2.3% from their previous closing price of $19.4. This decline was a surprise to many investors given the optimism surrounding the company’s recent acquisitions and partnerships, which had been expected to result in an increase in the stock price. This was mainly attributed to the strong performance of their pharmaceutical division, which saw an increase of 17%. Despite the overall increase in revenue, there was some disappointment in the company’s bottom line.

This was mainly due to higher costs associated with their acquisitions and higher taxes, which resulted in a lower net income than many analysts had expected. Overall, BAUSCH & LOMB remains confident in their ability to continue to grow and increase their profitability in the long term. Despite the slight dip in their stock price, investors remain optimistic about the future of the company as they continue to make strategic partnerships and acquisitions. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for BLCO. More…

    Total Revenues Net Income Net Margin
    3.9k -141 -2.8%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for BLCO. More…

    Operations Investing Financing
    106 -231 65
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for BLCO. More…

    Total Assets Total Liabilities Book Value Per Share
    11.31k 4.29k 19.87
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for BLCO are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    -0.1% -22.0% 3.4%
    FCF Margin ROE ROA
    -1.5% 1.2% 0.7%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis – BLCO Intrinsic Stock Value

    GoodWhale has conducted an analysis of BAUSCH & LOMB’s wellbeing. After careful consideration, our proprietary Valuation Line has determined that the intrinsic value of BAUSCH & LOMB share is around $16.9. However, we have observed that currently BAUSCH & LOMB stock is traded at $18.9, which is a fair price but slightly overvalued by 11.7%. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis

  • Summary

    BAUSCH & LOMB reported their second quarter FY2023 earnings results on August 2 2023. Revenue increased 10.0% year-over-year to USD 1035.0 million, while net income decreased to USD -32.0 million from the same quarter’s USD 5.0 million in the previous year. This marks a major shift for the company, with investors now needing to pay close attention to the company’s performance going forward. BAUSCH & LOMB will need to take steps to reduce expenses and improve profitability in order to appeal to investors.

    Additionally, changing consumer trends and competitive pressures must be monitored in order to make informed investing decisions.

    Recent Posts

    Leave a Comment